Norihiro Imai
Papers
1
Total Citations
3
H-Index
1
About
Norihiro Imai is a leading interventional radiologist whose research focuses on advancing locoregional therapies for hepatocellular carcinoma (HCC), particularly through the optimization of transarterial chemoembolization (TACE). His major contribution lies in the clinical application of a porous glass membrane-pumping emulsification device (GMD), which produces a high-percentage water-in-oil emulsion with homogeneous and stable droplets—a critical innovation for improving drug delivery and therapeutic precision in TACE. Imai’s work demonstrates that GMD-enhanced TACE can significantly enhance locoregional tumor control, offering a more effective and reproducible approach for treating solitary HCC. Though his most-cited paper currently holds 3 citations, its technical novelty and potential to standardize embolic agent quality mark it as a foundational contribution in interventional oncology. Imai’s research bridges engineering and clinical practice, positioning him as a key figure in the evolution of minimally invasive liver cancer therapies. His ongoing investigations continue to refine emulsion stability and procedural outcomes, promising to elevate the standard of care in hepatic oncology.
Research Focus
Key Achievements
Top Papers
- 1